PRME - Prime Medicine, Inc.

4.05
-0.060   -1.481%

Share volume: 2,250,167
Last Updated: 03-10-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: -0.03%

PREVIOUS CLOSE
CHG
CHG%
$4.11
-0.06
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 09-30-2025 12-31-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q3 2025 Q4 2025
Report Date 05-10-2024 08-08-2024 11-12-2024 02-28-2025 05-08-2025 11-07-2025 03-03-2026
Total revenue 591.000 K 0.000 209.000 K 2.183 M 1.454 M 1.225 M 838.000 K
Cost of revenue 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Gross profit 591.000 K 0.000 209.000 K 2.183 M 1.454 M 1.225 M 838.000 K
    -100.00% inf% 944.50% -33.39% -15.75% -31.59%  
Operating expenses 48.932 M 55.672 M 54.441 M 46.405 M 53.846 M 55.198 M 49.446 M
Selling general and admin 11.158 M 12.601 M 14.101 M 12.301 M 13.284 M 11.208 M 14.737 M
Research and development 37.774 M 43.071 M 40.340 M 34.104 M 40.562 M 43.990 M 34.709 M
Total expenses 48.932 M 55.672 M 54.441 M 46.405 M 53.846 M 55.198 M 49.446 M
    13.77% -2.21% -14.76% 16.03% 2.51% -10.42%  
Operating income -48.341 M -55.672 M -54.232 M -44.222 M -52.392 M -53.973 M -48.608 M
Ebit -45.627 M -56.072 M -53.215 M -44.490 M -53.072 M -51.723 M -47.162 M
Pretax income -45.627 M -55.461 M -52.518 M -42.276 M -51.890 M -50.582 M -46.079 M
    21.55% -5.31% -19.50% 22.74% -2.52% -8.90%  
Income tax 134.000 K -134.000 K 0.000 0.000 0.000 0.000 0.000
Net income basic 0.000 0.000 0.000 0.000 0.000 0.000 0.000
                 
Net income -45.761 M -55.327 M -52.518 M -42.276 M -51.890 M -50.582 M -46.079 M
    -20.90% 5.08% 19.50% -22.74% 2.52% 8.90%